Embla Medical hf
Embla Medical's GHG Emissions Data Preview
In 2024, Embla Medical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Embla Medical has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Embla Medical's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Embla Medical amounted to 6,620 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Embla Medical increased by 2.64%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Embla Medical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Embla Medical's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Embla Medical were 2,290 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Embla Medical reduced its Scope 1 emissions over time?
Since 2019, Embla Medical's Scope 1 emissions have decreased by 17.33%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Embla Medical's Scope 1 emissions decreased by 6.91%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Embla Medical's Scope 2 emissions?
In 2024, Embla Medical reported Scope 2 greenhouse gas (GHG) emissions of 310 tCOâ‚‚e using the market-based method, and 4,330 tCOâ‚‚e using the location-based method.
Has Embla Medical reduced its Scope 2 emissions over time?
Since 2019, Embla Medical's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 11.45%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2023), Embla Medical's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Embla Medical 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Embla Medical use for Scope 2 reporting?
In 2024, Embla Medical reported its Scope 2 emissions using the market-based method and using the location-based method.
Embla Medical's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Embla Medical's Value Chain Emissions
In 2024, Embla Medical reported 109,110 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of Embla Medical includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Embla Medical's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Embla Medical's Scope 3 emissions?
In 2024, Embla Medical reported total Scope 3 emissions of 109,110 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 99.51% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.49% came from downstream activities like product use, distribution, and end-of-life treatment.
Compared to the previous year (2023), Embla Medical's Scope 3 emissions remained relatively stable, indicating that Embla Medical 's emissions have plateaued with no significant change in its value chain footprint.
What categories of Scope 3 emissions does Embla Medical disclose?
In 2024, Embla Medical reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of Embla Medical's Scope 3 emissions?
In 2024, the largest contributors to Embla Medical's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 73,820 tCOâ‚‚e (67.66%)
- Upstream Transportation and Distribution (Cat. 4): 11,240 tCOâ‚‚e (10.3%)
- Employee Commuting (Cat. 7): 7,870 tCOâ‚‚e (7.21%)
Embla Medical's Scope 3 Emissions by Categories
Insights into Embla Medical's Total Carbon Footprint
In 2024, Embla Medical reported a total carbon footprint of 115,730 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 4.9% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Embla Medical's total carbon footprint was Scope 3 emissions, accounting for 94.28% of the company's total carbon footprint, followed by Scope 2 emissions at 3.74%.